Your web browser is out of date.

For your security and improved experience online, please update your browser.

Diabetes on the Net is intended for healthcare professionals

For healthcare professionals in the UK and Ireland only

The bigger picture of type 2 diabetes:

How to optimise care in the current climate

Your data is being collected by OmniaMed Communications on behalf of Boehringer Ingelheim solely for the purposes of processing your registration. Your details will not be shared with any other parties other than OmniaMed Communications and Boehringer Ingelheim.

By clicking Register, you submit your information to Boehringer Ingelheim Limited and OmniaMed Communications, who will use it to communicate with you regarding this event. To learn how Boehringer Ingelheim will handle personal information, please review our Privacy Policy.*

By registering I acknowledge and understand that my personal information (including full name, email and institution) will be shared with Eli Lilly for the purposes of documentation and relevant communications for this webcast, and for Lilly to contact me regarding any Adverse Events or product complaints I may mention in accordance with the privacy policy of Eli Lilly and Company, which can be found here.

The Boehringer Ingelheim and Lilly Alliance has provided the funding for this promotional webcast intended for Healthcare Professionals only, including speaker honoraria and presentation development support where applicable. Boehringer Ingelheim and Lilly Alliance products will be discussed in this webcast. Marketing and organisational support has been provided by OmniaMed Communications.
Adverse events should be reported. Reporting forms and information can be found at http://www.mhra.gov.uk/yellowcard (UK) or
https://www.hpra.ie/homepage/about-us/report-an-issue (Ireland). Adverse events should also be reported to Boehringer Ingelheim Drug Safety on
0800 328 1627 (freephone) (UK) or 01 2913960 (Ireland), Fax: +44 1344 742661, or by e-mail: PV_local_UK_Ireland@boehringer-ingelheim.com (Ireland).
PC-GB-105793 | October 2021

Thank you for registering.

We look forward to welcoming you online. You will receive a confirmation email shortly and we will send you a reminder email closer to the start of the virtual meeting.

Practical experiences from running an adeno-associated virus gene therapy trials: The Principal Investigator’s perspective

XX September 2020

Complete the registration form

XX Month 2020

Complete the registration form

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.